bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler aurobindo pharma limited
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 59651-847
Product ID 59651-847_b9ab1deb-dba4-4403-9121-936278cc4cfe
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090325
Listing Expiration 2026-12-31
Marketing Start 2025-06-03

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59651847
Hyphenated Format 59651-847

Supplemental Identifiers

RxCUI
993503 993518 993536
UPC
0359651847015
UNII
ZG7E5POY8O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA090325 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-847-01)
  • 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-847-05)
source: ndc

Packages (2)

59651-847-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-847-01) 59651-847-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-847-05)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b9ab1deb-dba4-4403-9121-936278cc4cfe", "openfda": {"upc": ["0359651847015"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["8f86f677-2ebd-43c4-b2dd-2e07d4d54147"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-847-01)", "package_ndc": "59651-847-01", "marketing_start_date": "20250603"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-847-05)", "package_ndc": "59651-847-05", "marketing_start_date": "20250603"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "59651-847_b9ab1deb-dba4-4403-9121-936278cc4cfe", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "59651-847", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090325", "marketing_category": "ANDA", "marketing_start_date": "20250603", "listing_expiration_date": "20261231"}